share_log

Earnings Update: Here's Why Analysts Just Lifted Their Hubei Dinglong CO.,Ltd. (SZSE:300054) Price Target To CN¥25.50

Earnings Update: Here's Why Analysts Just Lifted Their Hubei Dinglong CO.,Ltd. (SZSE:300054) Price Target To CN¥25.50

最新業績:這就是分析師剛剛解散湖北鼎龍股份的原因, Ltd.(深圳證券交易所代碼:300054)目標股價至25.50元人民幣
Simply Wall St ·  04/11 19:09

Hubei Dinglong CO.,Ltd. (SZSE:300054) just released its latest full-year report and things are not looking great. Results look to have been somewhat negative - revenue fell 3.3% short of analyst estimates at CN¥2.7b, and statutory earnings of CN¥0.24 per share missed forecasts by 4.7%. Earnings are an important time for investors, as they can track a company's performance, look at what the analysts are forecasting for next year, and see if there's been a change in sentiment towards the company. We thought readers would find it interesting to see the analysts latest (statutory) post-earnings forecasts for next year.

湖北鼎龍股份有限公司,Ltd.(深圳證券交易所代碼:300054)剛剛發佈了最新的全年報告,但情況看起來並不樂觀。業績似乎有些負面——收入比分析師預期的27億元人民幣低3.3%,每股0.24元人民幣的法定收益比預期低4.7%。對於投資者來說,盈利是一個重要時刻,因爲他們可以追蹤公司的業績,查看分析師對明年的預測,看看對公司的情緒是否發生了變化。我們認爲,讀者會發現分析師對明年最新(法定)業績後的預測很有趣。

earnings-and-revenue-growth
SZSE:300054 Earnings and Revenue Growth April 11th 2024
深圳證券交易所:300054 2024年4月11日收益和收入增長

After the latest results, the eight analysts covering Hubei DinglongLtd are now predicting revenues of CN¥3.14b in 2024. If met, this would reflect a meaningful 18% improvement in revenue compared to the last 12 months. Statutory earnings per share are predicted to jump 86% to CN¥0.44. Yet prior to the latest earnings, the analysts had been anticipated revenues of CN¥3.27b and earnings per share (EPS) of CN¥0.51 in 2024. The analysts seem less optimistic after the recent results, reducing their revenue forecasts and making a substantial drop in earnings per share numbers.

最新業績公佈後,報道湖北鼎龍股份有限公司的八位分析師現在預測2024年的收入爲31.4億元人民幣。如果得到滿足,這將反映出收入與過去12個月相比有18%的顯著增長。預計每股法定收益將增長86%,至0.44元人民幣。然而,在最新業績公佈之前,分析師曾預計2024年的收入爲32.7億元人民幣,每股收益(EPS)爲0.51元人民幣。在最近的業績公佈後,分析師似乎不那麼樂觀,他們下調了收入預期,使每股收益大幅下降。

What's most unexpected is that the consensus price target rose 12% to CN¥25.50, strongly implying the downgrade to forecasts is not expected to be more than a temporary blip. Fixating on a single price target can be unwise though, since the consensus target is effectively the average of analyst price targets. As a result, some investors like to look at the range of estimates to see if there are any diverging opinions on the company's valuation. There are some variant perceptions on Hubei DinglongLtd, with the most bullish analyst valuing it at CN¥27.00 and the most bearish at CN¥24.00 per share. With such a narrow range of valuations, the analysts apparently share similar views on what they think the business is worth.

最出乎意料的是,共識目標股價上漲了12%,至25.50元人民幣,這強烈意味着預測的下調預計只不過是暫時性的。但是,固定單一價格目標可能是不明智的,因爲共識目標實際上是分析師目標股價的平均值。因此,一些投資者喜歡查看估計範圍,看看對公司的估值是否有任何分歧。對湖北鼎龍股份有一些不同的看法,最看漲的分析師將其估值爲27.00元人民幣,最看跌的爲每股24.00元人民幣。由於估值範圍如此狹窄,分析師顯然對他們認爲的業務價值有相似的看法。

Looking at the bigger picture now, one of the ways we can make sense of these forecasts is to see how they measure up against both past performance and industry growth estimates. The period to the end of 2024 brings more of the same, according to the analysts, with revenue forecast to display 18% growth on an annualised basis. That is in line with its 19% annual growth over the past five years. Compare this with the broader industry, which analyst estimates (in aggregate) suggest will see revenues grow 16% annually. It's clear that while Hubei DinglongLtd's revenue growth is expected to continue on its current trajectory, it's only expected to grow in line with the industry itself.

從現在的大局來看,我們可以理解這些預測的方法之一是看看它們如何與過去的業績和行業增長預期相比較。分析師表示,截至2024年底將帶來更多相同的情況,收入按年計算預計將增長18%。這與其在過去五年中19%的年增長率一致。相比之下,分析師估計(總計),整個行業的收入每年將增長16%。很明顯,儘管湖北鼎龍有限公司的收入增長有望繼續保持目前的軌跡,但預計只會與行業本身保持同步。

The Bottom Line

底線

The biggest concern is that the analysts reduced their earnings per share estimates, suggesting business headwinds could lay ahead for Hubei DinglongLtd. They also downgraded their revenue estimates, although as we saw earlier, forecast growth is only expected to be about the same as the wider industry. We note an upgrade to the price target, suggesting that the analysts believes the intrinsic value of the business is likely to improve over time.

最大的擔憂是,分析師下調了每股收益的預期,這表明湖北鼎龍股份可能面臨業務不利因素。他們還下調了收入預期,儘管正如我們之前看到的那樣,預計增長僅與整個行業大致相同。我們注意到目標股價已上調,這表明分析師認爲該業務的內在價值可能會隨着時間的推移而提高。

Keeping that in mind, we still think that the longer term trajectory of the business is much more important for investors to consider. We have estimates - from multiple Hubei DinglongLtd analysts - going out to 2026, and you can see them free on our platform here.

考慮到這一點,我們仍然認爲該業務的長期發展軌跡對於投資者來說更爲重要。根據多位湖北鼎龍分析師的估計,預計將持續到2026年,你可以在我們的平台上免費查看。

That said, it's still necessary to consider the ever-present spectre of investment risk. We've identified 1 warning sign with Hubei DinglongLtd , and understanding it should be part of your investment process.

儘管如此,仍然有必要考慮永遠存在的投資風險陰影。我們已經向湖北鼎龍確定了1個警告信號,我們知道這應該是您投資過程的一部分。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論